Geoffrey Pires

1.2k total citations · 1 hit paper
18 papers, 731 citations indexed

About

Geoffrey Pires is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Geoffrey Pires has authored 18 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 14 papers in Molecular Biology and 5 papers in Psychiatry and Mental health. Recurrent topics in Geoffrey Pires's work include Alzheimer's disease research and treatments (16 papers), Mitochondrial Function and Pathology (6 papers) and Neuroscience and Neuropharmacology Research (4 papers). Geoffrey Pires is often cited by papers focused on Alzheimer's disease research and treatments (16 papers), Mitochondrial Function and Pathology (6 papers) and Neuroscience and Neuropharmacology Research (4 papers). Geoffrey Pires collaborates with scholars based in United States, Australia and France. Geoffrey Pires's co-authors include Eleanor Drummond, Thomas Wısnıewskı, Beatrix Ueberheide, Manor Askenazi, Shruti Nayak, Jiri Safar, Marie Bourdon, Tomas Kavanagh, Arline Faustin and Evgeny Kanshin and has published in prestigious journals such as Nature Communications, Nature Cell Biology and Brain.

In The Last Decade

Geoffrey Pires

17 papers receiving 725 citations

Hit Papers

Compilation of reported protein changes in the brain in A... 2023 2026 2024 2025 2023 25 50 75

Peers

Geoffrey Pires
Norelle C. Wildburger United States
Lonnie Schneider United States
Andreas Güntert United Kingdom
Marina Bigl Germany
Ashley N. Nilson United States
Jose A. Gonzalez United States
Norelle C. Wildburger United States
Geoffrey Pires
Citations per year, relative to Geoffrey Pires Geoffrey Pires (= 1×) peers Norelle C. Wildburger

Countries citing papers authored by Geoffrey Pires

Since Specialization
Citations

This map shows the geographic impact of Geoffrey Pires's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Pires with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Pires more than expected).

Fields of papers citing papers by Geoffrey Pires

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey Pires. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Pires. The network helps show where Geoffrey Pires may publish in the future.

Co-authorship network of co-authors of Geoffrey Pires

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey Pires. A scholar is included among the top collaborators of Geoffrey Pires based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey Pires. Geoffrey Pires is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Leitner, Dominique, Geoffrey Pires, Tomas Kavanagh, et al.. (2024). Similar brain proteomic signatures in Alzheimer’s disease and epilepsy. Acta Neuropathologica. 147(1). 27–27. 15 indexed citations
2.
Askenazi, Manor, Arline Faustin, Dominique Leitner, et al.. (2024). The influence of APOEε4 on the pTau interactome in sporadic Alzheimer’s disease. Acta Neuropathologica. 147(1). 91–91. 13 indexed citations
3.
Leitner, Dominique, Tomas Kavanagh, Evgeny Kanshin, et al.. (2024). Differences in the cerebral amyloid angiopathy proteome in Alzheimer’s disease and mild cognitive impairment. Acta Neuropathologica. 148(1). 9–9. 7 indexed citations
4.
Askenazi, Manor, Tomas Kavanagh, Geoffrey Pires, et al.. (2023). Compilation of reported protein changes in the brain in Alzheimer’s disease. Nature Communications. 14(1). 4466–4466. 81 indexed citations breakdown →
5.
Drummond, Eleanor, Tomas Kavanagh, Geoffrey Pires, et al.. (2022). The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome. Acta Neuropathologica Communications. 10(1). 53–53. 75 indexed citations
6.
Pires, Geoffrey, Beatrix Ueberheide, Thomas Wısnıewskı, & Eleanor Drummond. (2022). Use of Affinity Purification–Mass Spectrometry to Identify Phosphorylated Tau Interactors in Alzheimer’s Disease. Methods in molecular biology. 2561. 263–277. 6 indexed citations
7.
Pires, Geoffrey, Dominique Leitner, Eleanor Drummond, et al.. (2021). Proteomic differences in the hippocampus and cortex of epilepsy brain tissue. Brain Communications. 3(2). fcab021–fcab021. 36 indexed citations
8.
Drummond, Eleanor & Geoffrey Pires. (2021). It takes more than tau to tangle: using proteomics to determine how phosphorylated tau mediates toxicity in neurodegenerative diseases. Neural Regeneration Research. 16(11). 2211–2211. 1 indexed citations
9.
Drummond, Eleanor, Geoffrey Pires, Manor Askenazi, et al.. (2020). Phosphorylated tau interactome in the human Alzheimer’s disease brain. Brain. 143(9). 2803–2817. 231 indexed citations
10.
Moro, Loredana, Daniele Simoneschi, Emma Kurz, et al.. (2020). Epigenetic silencing of the ubiquitin ligase subunit FBXL7 impairs c-SRC degradation and promotes epithelial-to-mesenchymal transition and metastasis. Nature Cell Biology. 22(9). 1130–1142. 37 indexed citations
11.
Pires, Geoffrey, Dominique Leitner, Evgeny Kanshin, et al.. (2020). Proteomic similarities in Alzheimer’s disease and epilepsy brains highlight the important role of tau. Alzheimer s & Dementia. 16(S2). 1 indexed citations
12.
Drummond, Eleanor, Geoffrey Pires, Manor Askenazi, et al.. (2020). Phosphorylated tau interactome in the human Alzheimer’s disease brain. Alzheimer s & Dementia. 16(S2). 4 indexed citations
13.
Pires, Geoffrey, Shiron Drusinsky, Glenda M. Halliday, et al.. (2019). Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer’s disease and not in other tauopathies. Acta Neuropathologica Communications. 7(1). 195–195. 29 indexed citations
14.
Drummond, Eleanor, Geoffrey Pires, Manor Askenazi, et al.. (2019). P4‐530: PHOSPHORYLATED TAU INTERACTOME IN THE HUMAN ALZHEIMER'S DISEASE BRAIN. Alzheimer s & Dementia. 15(7S_Part_29). 1 indexed citations
15.
Pires, Geoffrey, Frances Prelli, Glenda M. Halliday, et al.. (2019). O4‐01‐06: SECERNIN‐1 IS A NOVEL PHOSPHORYLATED TAU BINDING PROTEIN THAT ACCUMULATES IN ALZHEIMER'S DISEASE AND NOT IN OTHER TAUOPATHIES. Alzheimer s & Dementia. 15(7S_Part_23). 1 indexed citations
16.
Drummond, Eleanor, Shruti Nayak, Geoffrey Pires, Beatrix Ueberheide, & Thomas Wısnıewskı. (2018). Isolation of Amyloid Plaques and Neurofibrillary Tangles from Archived Alzheimer’s Disease Tissue Using Laser-Capture Microdissection for Downstream Proteomics. Methods in molecular biology. 1723. 319–334. 37 indexed citations
17.
Drummond, Eleanor, Shruti Nayak, Arline Faustin, et al.. (2017). Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer’s disease. Acta Neuropathologica. 133(6). 933–954. 156 indexed citations
18.
Drummond, Eleanor, Shruti Nayak, Arline Faustin, et al.. (2016). O5‐04‐02: Altered Protein Expression in Amyloid Plaques in Rapidly Progressive Alzheimer's Disease. Alzheimer s & Dementia. 12(7S_Part_8).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026